abstract |
The present inventors have succeeded in producing monoclonal antibodies specific to soluble Αβ oligomers without recognizing soluble Αβ monomers, which are physiological molecules, and have found that the antibodies are useful as monoclonal antibodies for diagnosis and treatment of Alzheimer's disease. . |